Revelation Biosciences Inc (REVB)

NASDAQ
Currency in USD
4.110
-0.160(-3.75%)
Closed
Pre Market
4.440+0.330(+8.03%)
REVB Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Unusual Pre-Market activity
Fair Value
Day's Range
4.0104.350
52 wk Range
3.34069.440
Key Statistics
Edit
Prev. Close
4.27
Open
4.3
Day's Range
4.01-4.35
52 wk Range
3.34-69.44
Volume
64.36K
Average Volume (3m)
250.64K
1-Year Change
-90.76%
Book Value / Share
26.03
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
REVB Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
170.725
Upside
+4,053.89%
Members' Sentiments
Bearish
Bullish
ProTips
2 analysts have revised their earnings upwards for the upcoming period
Show more

Revelation Biosciences Company Profile

Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. It engages in developing therapeutic product candidates, including GEM-SSI, a potential therapy for the prevention and treatment of surgical sit infection; GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease. The company was founded in 2020 and is based in San Diego, California.

Compare REVB to Peers and Sector

Metrics to compare
REVB
Peers
Sector
Relationship
P/E Ratio
−0.1x−11.4x−0.6x
PEG Ratio
0.00−0.170.00
Price/Book
0.6x3.7x2.6x
Price / LTM Sales
-8.0x3.1x
Upside (Analyst Target)
-91.5%47.1%
Fair Value Upside
Unlock−14.0%8.1%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 170.725
(+4,053.89% Upside)

Earnings

Latest Release
Mar 01, 2023
EPS / Forecast
-1.69 / -52.50
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

FAQ

What Is the Revelation Biosciences (REVB) Stock Price Today?

The Revelation Biosciences stock price today is 4.11.

What Stock Exchange Does Revelation Biosciences Trade On?

Revelation Biosciences is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Revelation Biosciences?

The stock symbol for Revelation Biosciences is "REVB."

What Is the Revelation Biosciences Market Cap?

As of today, Revelation Biosciences market cap is 1.66M.

What is Revelation Biosciences Earnings Per Share?

The Revelation Biosciences EPS is -174.84.

From a Technical Analysis Perspective, Is REVB a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.